Phycotoxin Purification via Ammonium Hydroxide Extraction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for industrial production of paralyzing phycotoxins like neosaxitoxin, saxitoxin, and gonyaulatoxins from cyanobacteria face challenges in generating large amounts and maintaining their biological activity during purification, leading to insufficient commercial availability for therapeutic and cosmetic applications.
Innovation Solution
A biotechnological process involving continuous culture of cyanobacteria under controlled conditions, followed by extraction, fractionation, and purification using solvent partitioning, solid phase partitioning, and high-performance chromatography to obtain high-yield, biologically active phycotoxins, ensuring their potent biological activity is retained throughout the process.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional extraction methods using HCl medium at low pH are used to purify phycotoxins, then extraction efficiency is improved, but biological activity is lost and product purity deteriorates due to difficulty in removing HCl
Solution Approach 1:
The patent changes the pH parameter from acidic (HCl medium at low pH) to basic (ammonium hydroxide medium at high pH). This parameter change resolves the contradiction because the basic conditions enable effective extraction of phycotoxins while preserving their biological activity and avoiding the problems associated with acid medium removal.
Solution Approach 2:
The patent uses ammonium hydroxide, a volatile base, which can be easily removed by evaporation. This replaces the problematic HCl medium with a reagent that leaves no difficult-to-remove residues, thereby maintaining product purity and biological activity while achieving good extraction efficiency.
2Manufacturing precision
If multiple purification steps are implemented to achieve high purity, then product purity is improved, but process complexity and time consumption increase
Solution Approach 1:
The patent segments the purification process into distinct functional stages: extraction with ammonium hydroxide, filtration to remove cellular debris, and concentration. This segmentation allows each step to be optimized independently, achieving high purity without requiring an excessive number of complex purification steps.
Solution Approach 2:
The patent uses selective extraction with ammonium hydroxide to take out phycotoxins from cyanobacterial cells. This extraction step selectively transfers the target compounds to the aqueous phase while leaving many impurities in the cellular material, thereby achieving purification with relatively simple subsequent steps.
3Productivity
If large-scale continuous culture is used to produce massive amounts of phycotoxins, then productivity is improved, but maintaining biological activity throughout the process becomes more difficult
Solution Approach 1:
The patent implements continuous culture of cyanobacteria under controlled conditions, maintaining constant production of phycotoxins. The basic extraction medium (ammonium hydroxide) is applied continuously to harvested biomass, ensuring that biological activity is preserved throughout the large-scale production process without degradation that would occur with batch processing or acidic conditions.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method achieves high-yield purification of neosaxitoxin, saxitoxin, and gonyaulatoxins, making them suitable for industrial-scale production, addressing the demand for therapeutic and cosmetic applications while maintaining their biological activity and stability.
Implementation Method 1
passing the supernatant through a solid matrix of diatomaceous earth, where phycotoxins are retained
Implementation Method 2
passing the eluate containing the phycotoxins through a matrix of activated charcoal, where again phycotoxins are retained
Implementation Method 3
subjecting the partially purified phycotoxin extract obtained in the previous step to a biochemical separation and fractioning process by preparative HPLC
Data Source
Figure 1~2
Figure 3~4
Figure 5~6
AI summary
This invention is related to a method for the industrial purification of biologically active phycotoxins that comprises providing a suitable amount of a phycotoxin source; if the phycotoxin source is a pellet, said pellet is lysed using suitable methods; the material from the cyanobacterial lysis is subjected to a cold extraction; obtaining a concentrate of the aqueous phase obtained in the previous step or the culture medium of the first step; centrifugating the concentrate to obtain a supernatant; passing the supernatant through a diatomaceous earth column and obtaining a phycotoxin-containing eluate; passing the eluate obtained in the previous step through activated charcoal columns; the eluate from the previous step is passed again through a diatomaceous earth column; the eluate from the previous step is left in an aqueous phase; the partially purified extract from the previous step is subjected to a preparative HPLC in several steps to obtain the pure biologically active phycotoxin.